Lapix Therapeutics Inc.

Form D Filings

Location
Boston, MA
Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001947620
All SEC Filings
View on sec.gov
Date Filed Security Types Amount Sold Diff Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
2/10/2025 Equity $3,300,956 $5,520,946 $6,000,000 $479,054 8/2/2024 2/10/2025 D/A 000194762025000001
8/19/2024 Equity $2,219,990 $2,219,990 $5,499,999 $3,280,009 8/2/2024 8/16/2024 D 000194762024000001
4/27/2023 Equity $5,947,478 $5,947,478 $14,557,480 $8,610,002 4/14/2023 4/27/2023 D 000194762023000001
10/18/2022 Other $1,247,500 $1,247,500 $1,500,000 $252,500 8/29/2022 10/18/2022 D 000194762022000002